These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 9627353)

  • 1. Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123.
    Hindié E; Mellière D; Jeanguillaume C; Perlemuter L; Chéhadé F; Galle P
    J Nucl Med; 1998 Jun; 39(6):1100-5. PubMed ID: 9627353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary hyperparathyroidism: is technetium 99m-Sestamibi/iodine-123 subtraction scanning the best procedure to locate enlarged glands before surgery?
    Hindié E; Melliere D; Simon D; Perlemuter L; Galle P
    J Clin Endocrinol Metab; 1995 Jan; 80(1):302-7. PubMed ID: 7829631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism.
    Casas AT; Burke GJ; Sathyanarayana ; Mansberger AR; Wei JP
    Am J Surg; 1993 Oct; 166(4):369-73. PubMed ID: 8214295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary hyperparathyroidism: higher success rate of first surgery after preoperative Tc-99m sestamibi-I-123 subtraction scanning.
    Hindié E; Mellière D; Perlemuter L; Jeanguillaume C; Galle P
    Radiology; 1997 Jul; 204(1):221-8. PubMed ID: 9205251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism.
    Neumann DR; Esselstyn CB; Go RT; Wong CO; Rice TW; Obuchowski NA
    AJR Am J Roentgenol; 1997 Dec; 169(6):1671-4. PubMed ID: 9393188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m-sestamibi imaging before reoperation for primary hyperparathyroidism.
    Chen CC; Skarulis MC; Fraker DL; Alexander R; Marx SJ; Spiegel AM
    J Nucl Med; 1995 Dec; 36(12):2186-91. PubMed ID: 8523102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with 99mTc-sestamibi and 123I.
    Caveny SA; Klingensmith WC; Martin WE; Sage-El A; McIntyre RC; Raeburn C; Wolfe P
    J Nucl Med Technol; 2012 Jun; 40(2):104-10. PubMed ID: 22566587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
    Leslie WD; Dupont JO; Bybel B; Riese KT
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
    Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-pertechnetate and Tc-99m-sestamibi radionuclide scans.
    Wei JP; Burke GJ; Mansberger AR
    Ann Surg; 1994 May; 219(5):568-72; discussion 572-3. PubMed ID: 8185405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands.
    Wei JP; Burke GJ; Mansberger AR
    Surgery; 1992 Dec; 112(6):1111-6; discussion 1116-7. PubMed ID: 1455313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
    Billy HT; Rimkus DR; Hartzman S; Latimer RG
    Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited sensitivity of parathyroid imaging with (99m)Tc-sestamibi/(123)I subtraction in an endemic goiter area.
    Rink T; Schroth HJ; Holle LH; Garth H
    J Nucl Med; 2002 Sep; 43(9):1175-80. PubMed ID: 12215555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative localization of parathyroid tissue with technetium-99m sestamibi 123I subtraction scanning.
    Thulé P; Thakore K; Vansant J; McGarity W; Weber C; Phillips LS
    J Clin Endocrinol Metab; 1994 Jan; 78(1):77-82. PubMed ID: 8288719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid imaging: the importance of pinhole collimation with both single- and dual-tracer acquisition.
    Klingensmith WC; Koo PJ; Summerlin A; Fehrenbach BW; Karki R; Shulman BC; Raeburn CD; McIntyre RC
    J Nucl Med Technol; 2013 Jun; 41(2):99-104. PubMed ID: 23539762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism.
    Hindié E; Urenã P; Jeanguillaume C; Mellière D; Berthelot JM; Menoyo-Calonge V; Chiappini-Briffa D; Janin A; Galle P
    Lancet; 1999 Jun; 353(9171):2200-4. PubMed ID: 10392985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sestamibi parathyroid imaging.
    McBiles M; Lambert AT; Cote MG; Kim SY
    Semin Nucl Med; 1995 Jul; 25(3):221-34. PubMed ID: 7570042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
    Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
    Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism.
    Casas AT; Burke GJ; Mansberger AR; Wei JP
    Am Surg; 1994 Jan; 60(1):12-6; discussion 16-7. PubMed ID: 8273968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.